Experts from BRG recently discussed the two presidential candidates' stances on key healthcare issues, including drug pricing ...

Many have lauded the digital transformation occurring in the healthcare sector. By modernizing its technology, the healthcare industry is moving away from inefficient methods of data exchange ...

A new study published in the New England Journal of Medicine Catalyst showed that Waymark’s community-based interventions lowered hospital and emergency department visits and improved care quality.

Oshi Health, a virtual gastrointestinal center of excellence, announced Wednesday that it snagged $60 million in Series C funding, which it will use to grow and reach more patients. New York City ...

The past few years have seen a surge in demand for healthcare AI. This doesn’t show any signs of stopping soon — with three-quarters of the country’s providers and payers reporting that they ...

Lung cancer can be treated with small molecules formulated as pills as well as biological medications that are injected or infused, both as standalone treatments or as part of drug combinations.

Suki, a company offering AI voice solutions to healthcare companies, has secured $70 million in Series D funding, it announced Thursday. The financing will help the company build new products.

What a difference a few years make. Previously, digital strategy in the biopharma industry consisted of a series of isolated projects and fragmented channels, websites, and portals. Today ...

Sanofi is deepening its commitment to targeted radiation therapies for cancer with a €300 million equity investment in a new entity pursuing next-generation radioligand therapies. The new entity ...

Asthma patients have many drug options, but many patients find these choices either inconvenient or inadequate for severe cases of the chronic respiratory condition. Upstream Bio is pursuing a ...

Shortly after releasing a scathing interim report in July that revealed how three players dominate the pharmacy benefit manager market and raise drug costs for patients, the Federal Trade ...

Gilead Sciences is voluntarily withdrawing cancer drug Trodelvy from the U.S. market as a treatment for advanced cases of urothelial carcinoma, a move that comes nearly five months after the ...